American Thoracic Society
1740 Broadway
New York
New York
10019
United States
Tel: 212-315-8700
Fax: 212-315-6498
Website: http://www.thoracic.org/
134 articles about American Thoracic Society
-
Pivotal data from Amgen’s and AstraZeneca’s NAVIGATOR Phase III trial show tezepelumab, a potential first-in-class human monoclonal antibody, reduced asthma aggravations and exacerbations requiring hospitalizations better than placebo in patients with severe asthma.
-
American College of Chest Physicians, American Lung Association, American Thoracic Society and COPD Foundation Statement on Importance of Patients with Chronic Lung Disease Wearing Facial Coverings During COVID-19 Pandemic
7/17/2020
Facial Coverings Proven Safe Way to Help Mitigate Infection Risk and Slow Down Global Spread
-
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
6/17/2020
United Therapeutics Corporation announced that key data from the INCREASE study of Tyvaso® Inhalation Solution in patients suffering from World Health Organization Group 3 pulmonary hypertension associated with interstitial lung disease will be presented at a Breaking News Session hosted by the American Thoracic Society on June 24, 2020.
-
Nationwide clinician-to-hospital matching system launched in response to an overwhelming need for assistance in current and emerging COVID-19 hotspots
4/15/2020
The Clinician Matching Network platform, a national-level clearinghouse designed to match qualified medical staff with hospitals and communities overwhelmed by the coronavirus pandemic, was launched through the joint efforts of the American College of Chest Physicians, the American Thoracic Society, and PA Consulting.
-
Germany-based Boehringer Ingelheim announced that its SENSCIS Phase III clinical trial met its primary endpoint, which was reduction in the annual rate of decline in forced vital capacity.
-
FASENRA® (benralizumab) reduces oral corticosteroid use and maintains long-term efficacy and safety profile in severe eosinophilic asthma
5/20/2019
Integrated analysis of a large cohort of continuously treated patients to be presented at American Thoracic Society 2019 International Conference
-
Veracyte Announces Clinical Validation Data Demonstrating Envisia Genomic Classifier's Performance In Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented At American Thoracic Society 2017
5/24/2017
-
Theravance Biopharma And Mylan Report Additional Phase lll Data For Revefenacin (TD-4208) In Several Presentations At 2017 American Thoracic Society
5/24/2017
-
Spyryx Biosciences Reports Positive Data On SPX-101 At American Thoracic Society International Conference
5/24/2017
-
Kamada Ltd. Presents Updated Data From Phase II Clinical Trial Of Inhaled Alpha-1-Antitrypsin For Treatment Of Alpha-1 Antitrypsin Deficiency At 2017 American Thoracic Society International Conference
5/24/2017
-
ProMetic Life Sci Presents New Data On PBI-4050 And Plasminogen At American Thoracic Society's 2017 International Conference
5/23/2017
-
New Data From Emulate's Asthma-on-Chip Presented At American Thoracic Society Annual Meeting
5/23/2017
-
Boehringer Ingelheim Release: American Thoracic Society 2017 Spiriva Respimat Improves Breathing For People With Asthma Regardless Of BMI Or Allergic Status
5/23/2017
-
Bellerophon Therapeutics Release: Positive Clinical Data On Inopulse Presented At The American Thoracic Society 113th International
5/23/2017
-
Olympus Medical Systems Corp. Extends Portfolio For EBUS-TBNA At American Thoracic Society
5/18/2017
-
Sunovion To Present Clinical Efficacy, Safety And Health-Related Quality Of Life Outcomes Data From Its Respiratory Franchise At The American Thoracic Society 2017 International Conference
5/15/2017
-
ndd Medical Technologies Debuts New Diagnostic Devices At The 2017 American Thoracic Society Conference
5/15/2017
-
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016
5/20/2016
-
Xencor Reports Complete Data Results From XmAb7195 Phase 1a Trial Showing Rapid Reduction Of Serum IgE In High IgE Atopic Subjects At American Thoracic Society 2016 International Conference
5/19/2016
-
Immunexpress Release: Septicyte LAB Outperforms Other Parameters For Distinguishing Sepsis In Data Presented At The American Thoracic Society International Conference
5/19/2016